tiprankstipranks
Advertisement
Advertisement

PMVP Stock Latest News

PMV Pharmaceuticals price target lowered to $5 from $6 at Oppenheimer
The FlyPMV Pharmaceuticals price target lowered to $5 from $6 at Oppenheimer
20d ago
PMVP
PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)
PremiumThe Fly
PMV Pharmaceuticals reports Q1 EPS (34c), consensus (38c)
20d ago
PMVP
PMVP Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PMVP Earnings this Week: How Will it Perform?
27d ago
PMVP
PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed
PremiumThe Fly
PMV Pharmaceuticals chair Rich Heyman to depart, Laurie Stelzer to succeed
1M ago
KLRA
PMVP
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI
PremiumThe Fly
PMV Pharmaceuticals price target lowered to $4 from $16 at Evercore ISI
2M ago
PMVP
PMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
PremiumCompany AnnouncementsPMV Pharmaceuticals Advances Rezatapopt Interaction Study, Signaling Steady Progress in TP53-Driven Oncology
3M ago
PMVP
PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)
Premium
The Fly
PMV Pharmaceuticals reports FY25 EPS ($1.48), consensus ($1.51)
3M ago
PMVP
PMV Pharmaceuticals sees cash runway to end of 2Q27
Premium
The Fly
PMV Pharmaceuticals sees cash runway to end of 2Q27
3M ago
PMVP
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Pmv Pharmaceuticals, Inc. (PMVP) Q4 Earnings Cheat Sheet
3M ago
PMVP
PMV Pharmaceuticals announces results of Phase 1 trial of rezatapopt in NEJM
PremiumThe Fly
PMV Pharmaceuticals announces results of Phase 1 trial of rezatapopt in NEJM
3M ago
PMVP
PMV Pharmaceuticals Reports Increased Quarterly Loss
PremiumCompany Announcements
PMV Pharmaceuticals Reports Increased Quarterly Loss
7M ago
PMVP
Promising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
PremiumRatings
Promising Developments in PMV Pharmaceuticals’ PYNNACLE Phase 2 Trial Boost Buy Rating
7M ago
PMVP
Buy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
PremiumRatingsBuy Rating Affirmed for PMV Pharmaceuticals Amid Stable Financials and Strategic Growth Potential
7M ago
PMVP
PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
Premium
The Fly
PMV Pharmaceuticals reports Q3 EPS (40c), consensus (40c)
7M ago
PMVP
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
Premium
Company Announcements
PMV Pharmaceuticals Advances Cancer Treatment with Promising Study on PC14586
7M ago
PMVP
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
PremiumRatings
Promising Developments in PMV Pharmaceuticals’ Ovarian Cancer Treatment Drive Buy Rating
7M ago
PMVP
PMV Pharmaceuticals announces updated rezatapopt monotherapy interim data
PremiumThe Fly
PMV Pharmaceuticals announces updated rezatapopt monotherapy interim data
7M ago
PMVP
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
PremiumRatings
Promising Phase 2 Trial Results and Strategic Plans Support Buy Rating for PMV Pharmaceuticals
9M ago
PMVP
PMV Pharmaceuticals Reports Promising Phase 2 Trial Results
PremiumCompany Announcements
PMV Pharmaceuticals Reports Promising Phase 2 Trial Results
9M ago
8K
PMVP
PMV Pharmaceuticals announces interim data from Phase 2 portion of PYNNACLE
PremiumThe FlyPMV Pharmaceuticals announces interim data from Phase 2 portion of PYNNACLE
9M ago
PMVP
PMV Pharmaceuticals Reports Q2 2025 Financial Results
Premium
Company Announcements
PMV Pharmaceuticals Reports Q2 2025 Financial Results
10M ago
PMVP
PMV Pharmaceuticals reports Q2 EPS (41c), consensus (38c)
Premium
The Fly
PMV Pharmaceuticals reports Q2 EPS (41c), consensus (38c)
10M ago
PMVP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >